Cks1 regulates human hepatocellular carcinoma cell progression through osteopontin expression

Area of Science:

• Molecular Biology
• Oncology
• Cell Cycle Regulation

Background:

• Precise cell cycle regulation is crucial for preventing cancer.
• Cks1 is an accessory factor for SCF^Skp2, regulating p27^Kip1 degradation and G1 to S phase transition.
• The role of Cks1 in hepatocellular carcinoma (HCC) progression requires further investigation.

Purpose of the Study:

• To investigate the role of Cks1 in the growth and progression of human HCC cells.
• To elucidate the molecular mechanisms underlying Cks1-mediated effects in HCC.
• To assess the prognostic significance of Cks1, DUSP16, and OPN in HCC patients.

Main Methods:

• Silencing Cks1 expression in Huh7 HCC cells.
• Assessing osteopontin (OPN) expression and its dependence on p27^Kip1.
• Investigating the involvement of ERK1/2 signaling and dual-specificity phosphatase 16 (DUSP16).
• Analyzing Cks1, OPN, and DUSP16 expression levels in HCC tissues and their correlation with patient survival.

Main Results:

• Cks1 silencing abrogated OPN expression in a p27^Kip1-dependent manner, inhibiting HCC cell proliferation, migration, and invasion.
• Cks1 regulates OPN expression via ERK1/2 signaling, potentially by suppressing DUSP16 or through a p27^Kip1-dependent mechanism.
• Elevated Cks1 and OPN, with decreased DUSP16, were observed in HCC tissues, correlating with poor patient survival.

Conclusions:

• Cks1 acts as a tumor promoter in HCC by upregulating the oncogenic protein OPN.
• The Cks1-DUSP16-ERK1/2-OPN axis represents a novel pathway in HCC progression.
• Cks1, OPN, and DUSP16 expression levels hold significant prognostic value for HCC patients.